| Name | Title | Contact Details |
|---|
Sonomed is a New Hyde Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.
Evergreen Research Corporation has performed contract product development with an emphasis on medical devices since 1988. Evergreen Research offers a complete range of development services from product definition and feasibility studies through detailed design to pilot-run and low-volume production.Their experience and resourceful staff, seasoned program management, and knowledge of regulations ensure customer satisfaction and compliance with regulatory requirements. Evergreen Research, Inc. also known as ERI, has developed advanced electromechanical and software-based products providing a complete range of development services, such as product requirements definition, project planning, risk management, comprehensive design expertise (electrical, mechanical, software and industrial), design documentation, verification and validation, clinical studies, regulatory approvals, production quality planning and much more. Evergreen Research Advantages include highly skilled electrical, mechanical, and software engineers, on-site regulatory and quality expertise, manufacturing capability to build prototypes and marketed products such as Therapeutic Devices, Diagnostic Systems, Medical Software and Medical Imaging products.
At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.
Dental Concepts is a Paramus, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.